 |
Chemotherapy Resistance and Oncogene Expression in Non-Small Cell Lung Cancer |
|
|
Thomas A. d'Amato, MD, PhD, Rodney J Landreneau, MD, William Ricketts, PhD, Weidong Huang, MD, PhD, Ricardo Parker, PhD, Eugene Mechetner, MD, Ing-Ru Yu, MS, and James D. Luketich, MD
Journal of Thoracic and Cardiovascular Surgery, 2007, 133: 352-363 |
| read more |
|
|
Biomarker Expression Profiles in Primary versus Metastatic Colorectal Tumors |
|
|
Ing-Ru Yu, Ricardo J. Parker, and Eugene Mechetner. Oncotech Inc., Tustin, CA.
American Association for Cancer Research, 2007, Abstract: #196 |
| read more |
|
|
Biomarker and In Vitro Chemoresistance Profiles of Undifferentiated Ovarian Cancers |
|
|
John Chan1, Jacob Shin1, Daniel Kapp1, Eugene Mechetner2, and Ing-Ru Yu2.
1Stanford University, Stanford, CA., 2Oncotech Inc., Tustin, CA.
American Association for Cancer Research, 2007, Abstract: #3488 |
| read more |
|
|
In Vitro Testing of Drug Cross-Resistance to Improve Standard Combination Chemotherapy Selection in Colorectal Cancer |
|
|
Ing-Ru Yu, M.S., Ricardo Parker, Ph.D., and Eugene Mechetner, Ph.D., Oncotech, Inc., Tustin, CA.
Association of Colon and Rectal Surgeons (ASCRS), 2007, Abstract: #A125 |
| read more |
|
|
Differential Gene Expression Associated with Early Tumor Recurrence and Long Disease Free Survival in Early Stage Non-Small Cell Lung Cancer |
|
|
1T.A. d’Amato, 2H.C. Fernando, 3B.Y. Chan, 4W.A. Ricketts, 5J.D. Luketich, 5R.J. Landreneau.
1Department of Surgery, Jefferson Medical College, Philadelphia, PA; 2Boston Medical Center, Boston, MA; 3UC Irvine, Irvine, CA; 4Oncotech Inc., Tustin, CA, 5University of Pittsburgh Medical Center, Pittsburgh, PA.
The Society of Surgical Oncology (SSO), 2007, Abstract: #140 |
| read more |
|
|
In Vitro Drug Resistance Profiles and Biomarker Expression in 414 Freshly Resected Esophageal Cancer Specimens |
|
|
Ing-Ru Yu, Ricardo Parker, and Eugene Mechetner. Oncotech Inc., Tustin, CA.
The Society of Surgical Oncology (SSO), 2007, Abstract: #244 |
| read more |
|
|
In Vitro Drug Resistance Profiles Correlate with DNA Ploidy and p53 Expression in 3,106 Endometrioid and Papillary Serous Adenocarcinomas of the Uterus |
|
|
Ing-Ru Yu, Weidong Huang, and Eugene Mechetner. Oncotech Inc., Tustin, CA.
Proc. of American Society of Clinical Oncology, 2006, Abstract # 5037: 1 |
| read more |
|
|
Correlating Signal Transduction Protein Kinase Levels, SNPs and Drug Resistance in Human Melanoma |
|
|
1David L. Smith, 2Michael van Waes and 1William A. Ricketts. 1Oncotech Inc., Tustin, CA.
2LI-COR Biosciences, Lincoln, NE.
American Association for Cancer Research (AACR), 2006, Abstract #925: 1 |
| read more |
|
|
Detecting Altered Expression and Activation of Signaling Pathways in Cisplatin Resistant Ovarian Cancer |
|
|
Snjezana Covic, David L. Smith, and William A. Ricketts. Oncotech, Inc., Tustin, CA.
American Association for Cancer Research (AACR), 2006, Abstract #5089: 1 |
| read more |
|
|
Detecting Altered Expression and Activation of Signaling Pathways in Cisplatin Resistant Ovarian Cancer |
|
|
Snjezana Covic, David L. Smith, and William A. Ricketts. Oncotech, Inc., Tustin, CA.
American Association for Cancer Research (AACR), 2006, Abstract #5089: 1 |
| read more |
|
|
Morphological and Immunohistochemical Assessment of In Vitro Cell Proliferation of Fresh Human Tumor Tissues in an Agarose-Based Assay |
|
|
Weidong Huang M.D., Ph.D., Yen Huynh, Linda Hiroshima, Dennis Bansil, Ing-Ru Yu M.S., Lilian Tee. Oncotech Inc., Tustin, CA.
American Association for Cancer Research (AACR), 2006, Abstract #5432: 1 |
| read more |
|
|
Identification of Amplifications and Deletions in Taxol Resistant Ovarian Cancer by Comparative Genomic Hybridization Screening |
|
|
David Smith, Bejan Shahbahrami, Snjezana Covic, William Ricketts, Oncotech, Inc., Tustin, CA.
SGO 2006 Annual Meeting, 2006, Abstract #799: 1 |
| read more |
|
|
A 96-well Soft Agar Based Assay for Testing Cell Lines and Tumors |
|
|
Alessandra Re and William A. Ricketts. Oncotech Inc., Tustin, CA.
American Association for Cancer Research (AACR), 2006, Abstract #1363: 1 |
| read more |
|
|
Association of DNA Ploidy and p53 Expression with 5-FU, CPT-11, and Oxaliplatin Resistance in the EDR Assay: A Study of 1,271 Colon Adenocarcinomas |
|
|
Weidong Huang, M.D., Ph.D., Ing-Ru Yu, Eugene Mechetner, Ph.D.,
Oncotech, Inc., Tustin, CA |
| read more |
|
|
Optimization of protocols and screening of Topoisomerase II-alpha for SNPs that predict response to etoposide and doxorubicin |
|
|
David L. Smith, William A. Ricketts and Michael van Waes. 1. Oncotech Inc, 15501 Red Hill Avenue, Tustin CA 92780 2. LI-COR Biosciences, 4308 Progressive Avenue, Lincoln NE 68504.
American Association for Cancer Research (AACR), 2005, Abstract #4457: 1 |
| read more |
|
|
In Vitro Extreme Chemotherapy Resistance Patterns for Resected Non-Small Cell Lung Cancer |
|
|
T. d'Amato1, *R. Landreneau2, *R. McKenna3, R. Santos2, R. Parker4
1University of California, San Diego, San Diego, CA, 2University of Pittsburgh Medical Center, Pittsburgh, PA, 3Cedar Sinai Medical Center, Los Angeles, CA, 4Oncotech Inc, Tustin, CA.
Annals of Thoracic Surgery, 2005, Abstract #42: 1 |
| read more |
|
|
The Possible Role of Chemoresistance Testing in the Era of Post Surgical Adjuvant Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) |
|
|
Ricardo S. Santos, M.D*., Amit N. Patel, M.D., Clark T. Gamblin, M.D., Hiran C. Fernando, M.D., James D. Luketich, M.D. and Rodney J. Landreneau, M.D. University of Pittsburgh Medical Center, Pittsburgh, PA.
CHEST 2004 Meeting, 2004, Abstract #1188: 1 |
| read more |
|
|
A Prospective Blinded Study of Predictive Value of Extreme Drug Resistance Assay in Patients Receiving CPT-11 for Recurrent Glioma |
|
|
Ricardo J. Parker, John P. Fruehauf, Rita Mehta, Emese Filka, and Timothy Cloughesy
Journal of Neuro-Oncology, 2004, 66: 365-375 |
| read more |
|
|
Survival outcomes in patients with recurrent ovarian cancer who were treated with chemoresistance assay-guided chemotherapy |
|
|
Vera Loizzi, John K Chan, Kathryn Osann, Fabio Cappuccini, Phillip J DiSaia, and Michael L Berman.
American Journal of Obstetrics and Gynecology, 2003, 189, number 5: 1301-1307 |
| read more |
|
|
In Vitro Chemoresistance and Biomarker Profiles are Unique for Histologic Subtypes of Epithelial Ovarian Cancer |
|
|
Noelle G Cloven*, Ainura Kyshtoobayeva, Robert A Burger, Ing-Ru Yu, John P Fruehauf.
Gynecologic Oncology, 2004, 92: 160-166 |
| read more |
|
|
In Vitro and Ex Vivo Activity of SDX-105 (Bendamustine) in Drug-Resistant Lymphoma cells |
|
|
Lorenzo M. Leoni, Brandi Bailey, Christina C. Niemeyer, Jack Reifert, Heather Bendall, Lisa Dauffenbach, and Christopher Kerfoot.
American Association for Cancer Research (AACR), 2004, Abstract #1215: 1 |
| read more |
|
|
In Vitro Dosing Schedules in Breast and Ovarian Cancer and the Relationship with Topoisomerase I Expression |
|
|
Christopher Kerfoot, Lisa Dauffenbach, Weidong Huang, John Fruehauf.
American Association for Cancer Research (AACR), 2004, Abstract #5387: 1 |
| read more |
|
|
CD117/KIT Expression and Alkylator Resistance in Solid Tumors |
|
|
John Fruehauf, Ainura Kyshtoobayeva, and Ing-Ru Yu.
American Association for Cancer Research (AACR), 2004, Abstract #1219: 1 |
| read more |
|
|
Antiangiogenesis Activity of Buthionine Sulfoximine (BSO) Related to Glutathione Depletion and Dynein Overexpression |
|
|
John P. Fruehauf, Lillian Tee, Carina Torres, and Lisa Dauffenbach.
American Association for Cancer Research (AACR), 2004, Abstract #59: 1 |
| read more |
|
|
In Vitro Activity of Tarceva™ in Primary Lung And Colon Cancer Cells |
|
|
Christopher A. Kerfoot, James Thompson, Michael Richardson, Deborah Pavich, Sunjay S. Ramsinghani, Audrey Goddard, David A. Eberhard.
American Association for Cancer Research (AACR), 2003, Abstract R3796: 1 |
| read more |
|
|
Application of Surface-Enhanced Laser Desorption/Ionization Technology to Discover Ovarian Cancer Biomarkers for Early Detection and Individualized Treatment |
|
|
Bejan Shahbahrami, Carina Torres, Lan Huynh, and John P. Fruehauf.
American Association for Cancer Research (AACR), 2003, Abstract # 5986: 1 |
| read more |
|
|
Enhanced Antimelanoma Activity After Exposure to BSO in Combination with Disulfiram |
|
|
Carina Torres, John P. Fruehauf, Lan Huynh, and Ricardo Parker.
American Association for Cancer Research (AACR), 2003, Abstract # 4643: 1 |
| read more |
|
|
Distinct Intrinsic and Dynamic Gene Expression Profiles Associated with Taxane Response in Breast and Ovarian Cancer |
|
|
john P. Fruehauf, Lisa Dauffenbach, Carina Torres, and Mike Petka.
American Association for Cancer Research (AACR), 2003, Abstract # 3998: 1 |
| read more |
|
|
Endothelial Cells Co-Cultured with Breast or Ovarian Cancer Demonstrated Differential Gene Expression and Apoptotic Response |
|
|
Lisa Dauffenbach, Carina Torres, and John Fruehauf.
American Association for Cancer Research (AACR), 2003, Abstract # 3325: 1 |
| read more |
|
|
Correlation of Tumor-Associated Biomarkers with In Vitro Drug Response (IVDR) in Malignant Gliomas |
|
|
Ricardo J. Parker, Raymond Haroun, Richard Clatterbuck, Chris Gibbons, Henry Brem, Steven Brem, Andrew Sloane, Geoffrey Barger, and John P. Fruehauf.
American Association for Cancer Research (AACR), 2003, Abstract # 2550: 1 |
| read more |
|
|
Development of an in Vitro Chemo-Radiation Response Assay for Cervical Carcinoma |
|
|
Bradley J. Monk, M.D., Robert A. Burger, M.D., Ricardo Parker, Ph.D., Eric H. Radany, M.D., Ph.D., Leslie Redpath, Ph.D., John P. Fruehauf, M.D., Ph.D.
Gynecologic Oncology, 2002, 87: 193-199 |
| read more |
|
|
Survival and Response Rates in Refractory Ovarian Cancer Treated with Chemoresistance Assay Guided Chemotherapy |
|
|
Vera Loizzi, John K Chan, Fabio Cappuccini, Kathryn Osann, Phillip J DiSaia, Michael L Berman.
International Gynecologic Cancer Society, 2002, Abstract #OV110: 1 |
| read more |
|
|
Association Between In Vitro Platinum Resistance in the EDR Assay and Clinical Outcomes for Ovarian Cancer Patients |
|
|
Robert W. Holloway, M.D., Rita S. Mehta, M.D., Neil J. Finkler, M.D., Kuo-Tung Li, M.S., Christine E. McLaren, Ph.D., Ricardo J. Parker, Ph.D., John P. Fruehauf, M.D., Ph.D.
Gynecologic Oncology, 2002, 87:1: 8-16 |
| read more |
|
|
In vitro assay-assisted treatment selection for women with breast or ovarian cancer |
|
|
JP Fruehauf
Endocrine-Related Cancer, 2002, 9: 171-182 |
| read more |
|
|
In Vitro Drug Response and Biomarker Profiles for Ovarian Cancer Specimens Obtained at Initial Debulking or after Neoadjuvant Chemotherapy (EORTC 55971) |
|
|
John P. Fruehauf, Ing-Ru Yu, Ricardo Parker
American Society of Clinical Oncology, 2002, Abstract #2177: 1 |
| read more |
|
|
Antiangiogenesis Effects of Docetaxel and L-Buthionine-S, R-Sulfoximine (BSO) on Tumor Derived Vascular Endothelial Cells |
|
|
Carina Torres, Ricardo Parker and John P. Fruehauf.
American Association for Cancer Research, 2002, Abstract #3920: 1 |
| read more |
|
|
Differential Gene Expression Analysis Genetically Fingerprints Tumors of Unknown Primary |
|
|
John P. Fruehauf, Ainura Kyshtoobayeva, Ing-Ru Yu, Debbie Pavich, Carina Torres, Kristin McGann, Bob Chan, Michael Petka, Patty Pang and Frank J. Kiesner
American Association for Cancer Research, 2002, Abstract #4502: 1 |
| read more |
|
|
The Relationship of Molecular Markers of p53 Function and Angiogenesis to Prognosis of Stage I Epithelial Ovarian Cancer |
|
|
Michael J Goodheart*, Stephen Rose, Justine M Ritchie, John P Fruehauf, Barry R Deyoung, Richard E Buller.
SGO 33rd Annual Meeting, 2002, Abstract #77: 1 |
| read more |
|
|
Breast cancer survival and in vitro tumor response in the extreme drug resistance assay |
|
|
Rita S. Mehta, Richard Bornstein, Ing-Ru Yu, Ricardo J. Parker, Christine E. McLaren, Khanh P. Nguyen, Kuo-Tung Li, and
John P. Fruehauf |
| read more |
|
|
Significant Association between Angiogenesis Index and Survival in Colorectal Cancer |
|
|
Edward A Wagner, M.D., Tammey J Naab, M.D., Ricardo J Parker, Ph.D., Rita S Mehta, M.D., Wayne Tuckson, M.D., Christine E McLaren, Ph.D., Khan Nguyen, Fitzroy Dawkins, M.D., A. Kyshtoobayeva, M.D., John P Fruehauf, M.D., Ph.D.
American Association for Cancer Research, 2000, Abstract # 1075: 1 |
| read more |
|
|
High Throughput Screening for MDR1 Substrate Specificity Using the MDR1 Shift Assay |
|
|
E. Mechetner, Ph.D., L. Tee, S.W. Park, J.P. Fruehauf, M.D., Ph.D.
American Association for Cancer Research, 2000, Abstract #656: 1 |
| read more |
|
|
In Vitro Drug Resistance Patterns in Epithelial Ovarian Cancer |
|
|
Krishnansu S Tewari, Rita S Mehta, Ingru-Yu, Ainura S Kyshtoobayeva, Alberto Manetta, John P Fruehauf.
SGO 32nd Annual Meeting, 2001, Abstract #143: 1 |
| read more |
|
|
Gene Array Analysis of In Vitro Drug Response |
|
|
Eugene Mechetner, John P. Fruehauf, Shubhra Mittal, Bejan Shabahrami, Deborah Pavich, Lillian Tee, Carina Torres.
American Association for Cancer Research, 2001, Abstract #2599: 1 |
| read more |
|
|
Gene Array Analysis of Endothelial Cells Isolated from Human Tumors: A New Approach to the Development of Antiangiogenesis Therapies |
|
|
Eugene Mechetner, John P. Fruehauf, Shubhra Mittal, Bejan Shabahrami, Deborah Pavich, Lillian Tee, Carina Torres.
American Association for Cancer Research, 2001, Abstract #3041: 1 |
| read more |
|
|
|
|
|
|
|
|
|
|
|
|
Looking for more information |
|
| |
|
|